» Articles » PMID: 29176693

A Study of Splicing Mutations in Disorders of Sex Development

Overview
Journal Sci Rep
Specialty Science
Date 2017 Nov 28
PMID 29176693
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of splicing sequence variants in genes responsible for sex development in humans may compromise correct biosynthesis of proteins involved in the normal development of gonads and external genitalia. In a cohort of Brazilian patients, we identified mutations in HSD17B3 and SRD5A2 which are both required for human sexual differentiation. A number of these mutations occurred within regions potentially critical for splicing regulation. Minigenes were used to validate the functional effect of mutations in both genes. We evaluated the c.277 + 2 T > G mutation in HSD17B3, and the c.544 G > A, c.548-44 T > G and c.278delG mutations in SRD5A2. We demonstrated that these mutations altered the splicing pattern of these genes. In a genomic era these results illustrate, and remind us, that sequence variants within exon-intron boundaries, which are primarily identified for diagnostic purposes and have unknown pathogenicity, need to be assessed with regards to their impact not only on protein expression, but also on mRNA splicing.

Citing Articles

Indole-3-propionic acid promotes hepatic stellate cells inactivation.

Ilha M, Sehgal R, Matilainen J, Rilla K, Kaminska D, Gandhi S J Transl Med. 2025; 23(1):253.

PMID: 40025530 PMC: 11871697. DOI: 10.1186/s12967-025-06266-z.


Two genetic variants in the SRD5A2 gene are found to be associated with sex differences in the disease characteristics of patients with chronic hepatitis B virus infection.

Duan H, Wang X, Qi W, Shi J, Han L, Wang G Biol Sex Differ. 2023; 14(1):68.

PMID: 37784175 PMC: 10546680. DOI: 10.1186/s13293-023-00553-4.


Disorder of Sex Development Due to 17-Beta-Hydroxysteroid Dehydrogenase Type 3 Deficiency: A Case Report and Review of 70 Different Mutations Reported in 239 Patients.

Goncalves C, Carrico J, Bastos M, Lemos M Int J Mol Sci. 2022; 23(17).

PMID: 36077423 PMC: 9456484. DOI: 10.3390/ijms231710026.


Splicing in the Diagnosis of Rare Disease: Advances and Challenges.

Lord J, Baralle D Front Genet. 2021; 12:689892.

PMID: 34276790 PMC: 8280750. DOI: 10.3389/fgene.2021.689892.

References
1.
Yates A, Akanni W, Amode M, Barrell D, Billis K, Carvalho-Silva D . Ensembl 2016. Nucleic Acids Res. 2015; 44(D1):D710-6. PMC: 4702834. DOI: 10.1093/nar/gkv1157. View

2.
Baralle F, Giudice J . Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 2017; 18(7):437-451. PMC: 6839889. DOI: 10.1038/nrm.2017.27. View

3.
Black D . Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem. 2003; 72:291-336. DOI: 10.1146/annurev.biochem.72.121801.161720. View

4.
Kondo Y, Oubridge C, van Roon A, Nagai K . Crystal structure of human U1 snRNP, a small nuclear ribonucleoprotein particle, reveals the mechanism of 5' splice site recognition. Elife. 2015; 4. PMC: 4383343. DOI: 10.7554/eLife.04986. View

5.
Baralle D, Baralle M . Splicing in action: assessing disease causing sequence changes. J Med Genet. 2005; 42(10):737-48. PMC: 1735933. DOI: 10.1136/jmg.2004.029538. View